GRECO, BEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 81
EU - Europa 72
AS - Asia 30
OC - Oceania 5
AF - Africa 1
Totale 189
Nazione #
US - Stati Uniti d'America 73
IT - Italia 37
SE - Svezia 10
CN - Cina 8
SG - Singapore 8
RU - Federazione Russa 6
DE - Germania 5
DO - Repubblica Dominicana 5
FR - Francia 5
IN - India 5
SA - Arabia Saudita 4
CA - Canada 3
GB - Regno Unito 3
IL - Israele 3
NZ - Nuova Zelanda 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
FI - Finlandia 1
JP - Giappone 1
MG - Madagascar 1
TW - Taiwan 1
Totale 189
Città #
Ashburn 17
Milan 10
Shanghai 6
Cotui 5
Al Qatif 4
Moscow 4
New York 4
Singapore 4
Boston 3
Cantù 3
Chapel Hill 3
Hadera 3
Osimo 3
Pavia 3
Philadelphia 3
Seattle 3
Baronissi 2
Boardman 2
Brescia 2
Burnaby 2
Burolo 2
Cambridge 2
Castenaso 2
Inman 2
Innsbruck 2
Los Banos 2
Lower Hutt 2
Manerbio 2
Nuremberg 2
Palo Alto 2
Pune 2
Rockville 2
Rome 2
Rozzano 2
San Jose 2
Strasbourg 2
Vijayawada 2
Washington 2
West Lafayette 2
Adelaide 1
Antananarivo 1
Arlington 1
Chicago 1
Christchurch 1
Dallas 1
Evanston 1
Frederiksberg 1
Guangzhou 1
Gunzenhausen 1
Lappeenranta 1
Lawrence 1
London 1
Magnolia 1
Melbourne 1
Mumbai 1
Munich 1
Ottawa 1
Princeton 1
San Diego 1
St Louis 1
Taichung 1
Ulm 1
Worcester 1
Wuxi 1
Yamagata 1
Zaragoza 1
Zurich 1
Totale 152
Nome #
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 104
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 26
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety 17
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 14
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 13
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 11
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? 11
Totale 196
Categoria #
all - tutte 1.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 3 4 0 0 0
2022/2023103 2 2 1 1 3 4 24 16 16 8 20 6
2023/202474 6 1 5 12 13 9 3 11 4 3 2 5
2024/202512 8 2 2 0 0 0 0 0 0 0 0 0
Totale 196